Medtronic (NYSE: MDT) today announced a new interim analysis evaluating automated sacral neuromodulation (SNM) therapy.

GE HealthCare Q1 results beat the Wall Street analyst consensus — but it lowered its full-year EPS guidance due to tariff impacts.

Teleflex (NYSE: TFX) announced that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device.